Transcription of Reflection paper on the dissolution specification …
{{id}} {{{paragraph}}}
30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website European Medicines Agency, 2016. Reproduction is authorised provided the source is acknowledged. 13 May 2016 1 EMA/332805/2016 2 Committee for Medicinal Products for Human use (CHMP) 3 Committee for Medicinal Products for Veterinary use (CVMP) 4 Quality Working Party (QWP) 5 Reflection paper on the dissolution specification for 6 generic oral immediate release products 7 Draft 8 Draft agreed by the QWP March 2016 Draft adopted by the CHMP for release for consultation March 2016 Draft adopted by the CVMP for release for consultation April 2016 Start of public consultation 13 May 2016 End of consultation (deadline for comments) 13 August 2016 9 Comments should be provided using this template.
generic oral immediate release products 15 Table of contents 16 Introduction ..... 3 17 Scope ..... 3 18 Definitions ..... 3
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
RELEASE FOR IMMEDIATE RELEASE KREWE, RELEASE FOR IMMEDIATE RELEASE KREWE ENERGY ACQUIRES LAPEYROUSE, For Immediate Release, Release, Municipal Metered Parking Lots During Holidays, Immediate, Prolonged and immediate release tablets, Metformin, Release Metformin, Dissolution Method Development for Immediate, Dissolution Method Development for Immediate Release, IMMEDIATE PRESS RELEASE, Superior Court of California FOR IMMEDIATE, Superior Court of California